Laxatives and antacids

Article Abstract:

The total UK retail market for antacids and laxatives is predicted to be worth 182 million pounds sterling by 2001. Some 17.5% of adults, who were questioned, used laxatives during 1996-1997, whilst 43.6% used stomach and indigestion preparations. Some 25,836 adults were surveyed. Sales of laxatives and antacids, in the UK, were worth 141 million pounds sterling in 1996 and are expected to rise to 147 million pounds sterling in 1997. Sales between 1992-97 are predicted to rise by 18%. Some 15.95 million pounds sterling was spent on marketing antacids and laxatives during 1996.

Antacid Preparations, Laxative Preparations, Antacids, Laxatives

---

Cough and throat remedies

Article Abstract:

The market for over-the-counter cough and throat remedies is estimated to be worth 207 million pounds sterling in 1996, up from 199 million pounds in 1995. Cough remedies boast 36% of the market, sore throat remedies 11%, and medicated confectionery 53%. Sales of these products are influenced by influenza epidemics. Rates of coughs and colds have remained stable since 1992. Emphasising the preventative qualities of the products is a potential growth area.

Proprietary Preparations, Product information, Market share, Proprietary drugs, Cold (Disease), Common cold

---

Cough and throat remedies

Article Abstract:

The UK market for cough and sore throat remedies is estimated at 214 million pounds sterling. Cough remedies account for 47% of total sales, but this sector is not expanding. Sales of sore throat remedies were worth 37 million pounds sterling in 1999.

Ethical Cough Preparations

Similar abstracts:

• Abstracts: Market structure and the pricing of electricity and natural gas. An empirical analysis of electricity regulation on technical changes in Texas
• Abstracts: Russia's foreign trade: new directions and western policies. Trade Policy During the Transition: Lessons from the 1990s
• Abstracts: Temporary and permanent government spending in a small open economy. Money, politics and the post-war business cycle
• Abstracts: Pricing and hedging derivative securities with neural networks and a homogeneity hint. Econometric specification of the risk neutral valuation model
• Abstracts: United States. part 3

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.